Salud
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
![](https://univciencia.com/wp-content/uploads/2024/05/rt-ultimo4-MEZPMQ.jpeg)
The addition of blinatumomab to consolidation chemotherapy in adults with B-cell precursor acute lymphoblastic leukemia who had minimal residual disease–negative status after treatment improved overall and relapse-free survival.
The New England Journal of Medicine: Search Results in Hematology/Oncology